Pharmaceutical composition for preventing or treating nonalcoholic fatty liver disease comprising a polypeptide

摘要

The present invention relates to a pharmaceutical composition for preventing or treating non-alcoholic fatty liver disease comprising a polypeptide, and more particularly, the polypeptide reduces food intake, promotes insulin secretion, suppresses gastric emptying, promotes lipolysis and It relates to a pharmaceutical composition for the prevention or treatment of non-alcoholic fatty liver disease that is safe without side effects such as vomiting or nausea while having a triglyceride reduction effect.